Public Health Conference Support Cooperative Agreement Program for Human Immunodeficiency Virus (HIV) Prevention

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Announcement Number 802]

Public Health Conference Support Cooperative Agreement Program

for Human Immunodeficiency Virus (HIV) Prevention

Introduction

The Centers for Disease Control and Prevention (CDC) announces the

availability of fiscal year (FY) 1998 funds for the Public Health

Conference Support Cooperative Agreement Program for Human

Immunodeficiency Virus (HIV) Prevention. CDC is committed to achieving

the health promotion and disease prevention objectives of Healthy

People 2000, a national activity to reduce morbidity and mortality and

improve the quality of life. This announcement is related to the

priority area of HIV Infection. (For ordering a copy of Healthy People

2000 and CDC's Strategic Plan for Preventing Human Immunodeficiency

Virus (HIV) Infection (July 8, 1992), see the section WHERE TO OBTAIN

ADDITIONAL INFORMATION.)

Authority

This program is authorized under Section 317(k)(2) [42 U.S.C.

247b(k)(2)] of the Public Health Service Act, as amended.

Smoke-Free Workplace

CDC strongly encourages all grant recipients to provide a smoke-

free workplace and promote the non-use of all tobacco products, and

Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in

certain facilities that receive Federal funds in which education,

library, day care, health care, or early childhood development services

are provided to children.

Eligible Applicants

Eligible applicants are non-profit organizations including

universities, colleges, research institutions, hospitals, other public

and private (e.g., national, regional) non-profit organizations and

federally recognized Indian tribal governments, Indian tribes or Indian

tribal organizations. State and local health departments may only apply

for funding under Category 2 (See Application Section).

Note: Organizations authorized under section 501(c)(4) of the

Internal Revenue Code of 1986 are not eligible to receive Federal

grant/cooperative agreement funds.

Availability of Funds

Approximately $400,000 is available in FY 1998 to fund

approximately 15 to 25 awards. It is expected that the average award

will be $20,000 and will be funded for a 12-month budget and project

period. Funding estimates may vary and are subject to change.

Use of Funds

CDC funds may be used for direct cost expenditures:

salaries, speaker fees, rental of conference related equipment,

registration fees, and transportation cost (not to exceed economy class

fares) for non-Federal employees.

CDC funds may be used for only those parts of the

conference specifically supported by CDC as documented in the Notice of

Cooperative Agreement (award document).

CDC funds may not be used for the purchase of equipment,

payments of honoraria, organizational dues, entertainment or personal

expenses, cost of travel and payment of a Federal

[[Page 66107]]

employee, or per diem or expenses, other than mileage, for local

participants.

CDC funds may not be used for reimbursement of indirect

costs.

CDC funds may not be used to purchase novelty items (e.g.,

bags, T-shirts, hats, pens) distributed at meetings.

CDC will not fund 100 percent of the proposed conference.

Part of the cost of the proposed conference must be supported with

other than Federal funds.

CDC will not fund a conference after it has taken place.

CDC funds may be used for only those parts of the

conference specifically supported by CDC as documented on the notice of

award.

Restrictions on Lobbying

Fiscal year 1997 appropriation lobbying language remains in full

effect as follows: Applicants should be aware of restrictions on the

use of HHS funds for lobbying under the requirements of Section 1352 of

Public Law 101-121, effective December 23, 1989. This law provides, in

pertinent part, that recipients (and their subtier contractors and/or

subgrantees) are prohibited from using appropriated Federal funds

(other than profits from a Federal contract) for lobbying Congress or

any Federal agency in connection with the award of a particular

contract, grant, cooperative agreement or loan. This would include

grants/cooperative agreements that, in whole or in part, involve

conferences for which Federal funds cannot be used directly or

indirectly encouraging participants to lobby or instructing

participants on how to lobby.

Section 503 of the Departments of Labor, Health and Human Services,

and Education, and Related Agencies Appropriations Act (Public Law 104-

208), effective October 1, 1996, establishes additional restrictions on

the use of Federal funds for lobbying. Whereas previous anti-lobbying

prohibitions involved only activities for or against passage of

legislation pending before the Congress, the FY 1997 appropriations

language establishes an additional prohibition against lobbying for or

against legislation pending before State legislatures:

Section 503(a): No part of any appropriation contained in the FY

1997 Appropriations Act shall be used, other than for normal and

recognized executive-legislative relationships, for publicity or

propaganda purposes, for the preparation, distribution, or use of any

kit, pamphlet, booklet, publication, radio, television, or video

presentation designed to support or defeat legislation pending before

the Congress, * * * except in presentation to the Congress itself or

any State legislature.

Section 503(b): No part of any appropriation contained in the Act

shall be used to pay the salary or expenses of any grant or contract

recipient, or agent acting for such recipient, related to any activity

designed to influence legislation or appropriations pending before the

Congress or any State legislature.

Under Section 503, any activity designed to influence action in

regard to a particular piece of pending legislation would be considered

``lobbying.'' That is, Section 503 prohibits lobbying for or against

pending legislation, as well as indirect or ``grass roots'' lobbying

efforts by award recipients that are directed at inducing members of

the public to contact their elected representatives at the Federal or

State levels to urge support of, or opposition to, pending legislative

proposals. As a matter of policy, CDC extends the prohibitions to

lobbying with respect to local legislation and local legislative

bodies.

The new provisions are not intended to prohibit all interaction

with the legislative branch, or to prohibit educational efforts

pertaining to public health. Clearly there are circumstances when it is

advisable and permissible to provide information to the legislative

branch in order to foster implementation of prevention strategies to

promote public health. However, it would not be permissible to

influence, directly or indirectly, a specific piece of pending

legislation.

It remains permissible to use CDC funds to engage in activity to

enhance prevention; collect and analyze data; publish and disseminate

results of research and surveillance data; implement prevention

strategies; conduct community outreach services; provide leadership and

training, and foster safe and healthful environments.

Recipients of CDC grants and cooperative agreements need to be

careful to prevent CDC funds from being used to influence or promote

pending legislation. With respect to conferences, public events,

publications, and ``grassroots'' activities that relate to specific

legislation, recipients of CDC funds should give close attention to

isolating and separating the appropriate use of CDC funds from non-CDC

funds. CDC also cautions recipients of CDC funds to be careful not to

give the appearance that CDC funds are being used to carry out

activities in a manner that is prohibited under Federal law.

Background

The HIV epidemic constitutes a significant threat to the public

health of the United States. The most recent estimate of HIV prevalence

indicates that between 650,000 and 900,000 Americans are living with

HIV. Recently, there has been a marked decrease in deaths among people

with AIDS. The decline in deaths is likely due to both the slowing of

the epidemic and to improved treatments over the past several years.

However, women and people of color are still disproportionately

affected by HIV. Declines in deaths were greater among whites (28

percent) than among blacks (10 percent) and Hispanics (16 percent).

Among women, AIDS deaths declined only 7 percent in the first three

quarters of 1996. HIV/AIDS remains a leading cause of death.

Although the number of AIDS cases in men who have sex with men has

declined, they continue to account for the largest proportion of

reported cases. In 1996, women represented 20 percent of adults and

adolescents reported with AIDS, greater than the proportion in any

previous year. Among women, heterosexual contact and injecting drug use

accounted for 40 percent and 34 percent, respectively, of cases

reported in 1996. For the first time, blacks represented 41 percent of

adults and adolescents reported with AIDS, exceeding the proportion in

the white population.

A great number of public and private health care providers have

made significant strides in developing effective strategies for HIV

information dissemination and prevention. However, mechanisms are

needed to disseminate information about the newest developments in

disease prevention, health promotion techniques, and their practical

applications nationwide.

CDC supports local, State, regional, national, and international

health efforts to prevent unnecessary disease, disability, and

premature death and to improve the quality of life. This support often

takes the form of education, including the transfer of research

findings and public health strategies and practices, through symposia,

seminars, and workshops. Through its support of conferences and

meetings related to the areas of public health research, education, and

prevention applications, CDC is a key participant in the dissemination

of essential prevention information and in the implementation of HIV

prevention programs.

National HIV Prevention Goal

Applications must be consistent with the CDC national goal of

assisting in building and maintaining the necessary

[[Page 66108]]

State, local, and community infrastructure and technical capacity to

carry out necessary HIV and STD prevention programs.

Purpose

The purpose of the HIV Prevention Conference Support funding is to

provide PARTIAL support for specific non-Federal conferences in the

areas of health promotion, disease prevention information and education

programs, and applied research. Because conference support by CDC

creates the appearance of CDC co-sponsorship, there will be active

participation by CDC in the development and approval of those portions

of the agenda supported by CDC funds. CDC funds will not be expended

for non-approved portions of conference. In addition, CDC will reserve

the right to approve or reject the content of the full agenda, press

events, promotional materials (including press releases), speaker

selection, and site selection. Contingency awards will be made allowing

usage of only 25 percent of the total amount to be awarded until a

final full agenda is approved by CDC. This will provide funds to

support costs associated with preparation of the agenda. The remainder

of funds will be released only upon approval of the final full agenda.

CDC reserves the right to terminate co-sponsorship at any time.

This program is not meant for conferences to educate the general

public or to deliver prevention interventions to persons at risk for

HIV infection.

Any conference sponsored by CDC shall be held in

facilities that are fully accessible to the public as required by the

Americans with Disabilities Act Accessibility Guidelines (ADAAG).

Accessibility under ADAAG addresses accommodations for persons with

sensory impairments as well as persons with physical disabilities or

mobility limitations. The Director, or his/her designee, of the CIO(s)

providing funds or approving CDC sponsorship of a conference must

assure that the proposed meeting facilities comply with ADAAG.

The conference organizer(s) may use CDC's name only in

factual publicity for the conference and should understand that CDC

involvement in the conference does not necessarily indicate support for

the organizer's general policies, activities, or products.

Topics concerned with issues and areas other than HIV prevention

should be directed to other public health agencies or in accordance

with the current Federal Register Notice (see Federal Register Notice

803, [61 FR 19296] published on April 29, 1997).

Program Requirements

Development of HIV prevention conferences may require substantial

CDC collaboration and involvement. In conducting activities to achieve

the purpose of this program, the recipient will be responsible for the

activities listed under A. (Recipient Activities) and CDC will be

responsible for the activities listed under B. (CDC Activities).

A. Recipient Activities

1. Manage all activities related to conference content (e.g.,

objectives, topics, participants, session design, workshops, special

exhibits, speakers, fees, agenda composition, printing). Many of these

items may be developed in concert with assigned CDC project personnel.

2. Provide draft copies of the agenda and proposed ancillary

activities to the CDC Grants Management Office for review and comment.

Submit a copy of the final agenda and proposed ancillary activities to

the CDC Grants Management Office for acceptance.

3. Determine and manage all promotional activities (e.g., title,

logo, announcements, mailers, press). CDC must review and approve the

use of any materials with reference to CDC involvement or support.

4. Manage all registration processes with participants, invitees,

and registrants (e.g., travel, reservations, correspondence, conference

materials and hand-outs, badges, registration procedures).

5. Plan, negotiate, and manage conference site arrangements,

including all audio-visual needs.

6. Develop and conduct education and training programs on HIV

prevention.

7. If the proposed conference is or includes a satellite broadcast:

a. Provide individual, on-camera rehearsals for all presenters,

b. Provide at least one full dress rehearsal involving the

moderator, all presenters, equipment, visuals, and practice telephone

calls at least one day before the actual broadcast and as close to the

actual broadcast time as possible,

c. Provide full scripting and Teleprompter use for the moderator

and all presenters,

d. Select a professional moderator.

8. Collaborate with CDC staff in reporting and disseminating

results and relevant HIV prevention and education and training

information to appropriate Federal, State, and local agencies, health-

care providers, HIV/AIDS prevention and service organizations, and the

general public.

B. CDC Activities

1. Provide technical assistance through telephone calls,

correspondence, and site visits in the areas of program agenda

development, implementation, and priority setting related to the

cooperative agreement.

2. Provide scientific collaboration for appropriate aspects of the

program, including selection of speakers, pertinent scientific

information on risk factors for HIV infection, preventive measures, and

program strategies for the prevention of HIV infection.

3. Review draft agendas and the Grants Management Officer will

issue approval or disapproval of the final agenda and proposed

ancillary activities prior to release of restricted funds.

4. Assist in the reporting and dissemination of research results

and relevant HIV prevention education and training information to

appropriate Federal, State, and local agencies, health-care providers,

the scientific community, and HIV/AIDS prevention and service

organizations, and the general public.

Technical Reporting Requirements

An original and two copies of final performance and financial

status reports (reporting actual expenses) are required no later than

90 days after the end of the budget/project period. The performance

report should include: (1) The cooperative agreement number; (2) title

of the conference; (3) name of the principal investigator, program

director or coordinator; (4) name of the organization that conducted

the conference; (5) a copy of the agenda; (6) a list of individuals who

participated in the formally planned sessions of the meeting; (7) a

summarization of the results of the meeting, including a discussion of

the accomplishments related to stated conference objectives; and (8)

the Program Review Panel's report that all written materials have been

reviewed as required (see the section Program Review Panel).

With the prior approval of CDC, copies of proceedings or

publications resulting from the conference may be substituted for the

final performance report, provided they contain the information

requested in items (1) through (8) above.

Application Content

Organizations should submit separate applications in any of the

three following categories:

Category 1: Regional, national, or international conferences for

[[Page 66109]]

individuals or organizations implementing HIV prevention programs or

providing relevant services. The focus will be on information exchange

including lessons learned and successful programs;

Category 2: Local, statewide, or regional conferences providing

information about technology transfer regarding interventions for

effective HIV prevention for a defined population within a specific

locality, State, or multi-state area (State and local health

departments may apply only under Category 2); and

Category 3: Regional, national, or international conferences for

researchers to impart theoretically based or empirically demonstrated

health research with the intention to train health and other

professionals in innovative, enhanced interventions, e.g., newly

emerging science-based interventions for health professionals.

A. Letter Of Intent (LOI)

Applicants must submit an original and two copies of a two-page

typewritten LOI that briefly describes the application category (1, 2,

or 3), title, location, proposed conference dates, purpose, target

population(s) (e.g., youth, women, Men Who Have Sex with Men (MSM),

Injecting Drug Users (IDU), and the intended audience (number and

description)). The LOI must also include the estimated total cost of

the conference, the percentage of the total cost (which must be less

than 100 percent) being requested from CDC, and the relationship of the

conference to CDC Topics of Special Interest (listed below).

Topics of Special Interest

1. Prevention of HIV infection among:

A. Under-served populations (e.g., women of reproductive age,

racial and ethnic minorities)

B. High-risk populations (e.g., men who have sex with men, drug

users, in-school and out-of-school youth, and migrant workers)

C. Populations in special settings (e.g., correctional

institutions)

D. Under-served geographic areas

Preferences may be given to supporting organizations that serve

multiple high-risk populations.

2. Development of HIV prevention strategies with a broad range of

community, regional, or national partners.

Preferences are established to include national priorities, to

ensure a balance of CDC HIV prevention funding, and to address at-risk

populations and geographic areas that are under-served. No preference

will be given to organizations that have received funding in past

years.

LOIs will be reviewed by CDC and an invitation to submit an

application will be made based on:

1. Documented need for the proposed conference,

2. Contribution to the prevention of HIV/AIDS,

3. National HIV prevention priorities based on emerging trends in

the epidemic,

4. The proposed conference's relationship to the CDC determined

topics of special interest,

5. Timing of the conference that will allow for CDC input, and

6. Availability of funds.

Also include the name, mailing address, telephone number, and if

available, fax number and e-mail address of the organization's primary

contact person. Current recipients of CDC HIV funding must provide the

award number and title of the funded programs. No attachments,

booklets, or other documents accompanying the LOI will be considered.

The two page limitation (inclusive of letterhead and signatures), must

be observed or the letter of intent will be returned without review.

B. Final Application

Applicants invited to apply must develop applications in accordance

with PHS Form 5161-1 (OMB Number 0937-0189). Pages must be clearly

numbered, and a complete index to the application and its appendices

must be included. The original and two required copies of the

application must be submitted unstapled and unbound. All material must

be typewritten in unreduced type on 8\1/2\ by 11'' paper, with at least

1'' margins, and printed on one side only. Materials which should be

part of the basic plan should not be in the appendices. Use the

evaluation criteria described below to develop your application. The

body of the application must be limited to 12 pages.

The following information must be included:

1. A project summary cover sheet that includes:

a. Application category (1, 2, or 3),

b. Name of organization,

c. Name of conference,

d. Location of conference,

e. Date (s) of conference,

f. Target population(s) (e.g., youth, women, MSM, IDU),

g. Intended audience and number,

h. Dollar amount requested,

i. Total conference budget.

2. Biographical sketches and job descriptions of the individuals

responsible for planning and coordinating the conference.

3. A Budget Narrative separately identifying and justifying line

items to which the requested Federal funds would be applied.

4. A draft agenda for the proposed conference.

5. Award number and title(s) of funded program(s) for current

recipients of CDC HIV funding. Must not have submitted the same

proposal for review for funding to other parts of CDC.

Evaluation Criteria

Applications will be reviewed and evaluated according to the

following criteria (TOTAL 100 POINTS).

1. Category-specific criterion (20 points):

A. Category 1: Extent to which the applicant provides evidence of

an opportunity for participants and presenters to interact during the

conference.

B. Category 2: Extent to which the applicant relates the specific

connection of the conference content to HIV prevention community

planning priorities and provides a description of need for the proposed

conference.

C. Category 3: Extent to which the applicant demonstrates the

scientific soundness of the technology to be transferred as evidenced

by inclusion in HIV prevention research publications, peer reviewed

journals, or scientific consensus panel review.

The following criteria apply to all applications:

2. Proposed Program and Technical Approach (30 points):

A. The extent to which the applicant's description of the proposed

conference relates to HIV prevention and education, including the

public health need of the proposed conference and the degree to which

the conference can be expected to influence public health practices,

and the extent of the applicant's collaboration with other agencies

serving the intended audience, including local health and education

agencies concerned with HIV prevention.

B. The applicant's description of conference objectives in terms of

quality, specificity, and the feasibility of the conference based on

the operational plan, and the extent to which evaluation mechanisms for

the conference adequately assess increased knowledge, attitudes, and

behaviors of the target participants.

C. The relevance and effectiveness of the proposed agenda in

addressing the chosen HIV prevention and education topic.

D. The degree to which conference activities proposed for CDC

funding

[[Page 66110]]

strictly adhere to the prevention of HIV transmission.

3. Applicant Capability (25 points):

A. The adequacy and commitment of institutional resources to

administer the program for the proposed conference.

B. The adequacy of existing and proposed facilities and resources

for conducting conference activities.

C. The degree to which the applicant has established and used

critical linkages with health and education departments and community

planning groups with the mandate for HIV prevention. Letters of support

(limit of 5) from such agencies addressing related capability and

experience should be included. They must explain how the agency will

work with the applicant to plan the proposed conference. Letters that

do not pertain directly to the proposed conference will not be

considered.

4. Qualifications of Program Personnel (25 points):

A. The qualifications, experience, and commitment of the principal

staff person, and his or her ability to devote adequate time and effort

to provide effective leadership.

B. The competence of associate staff persons, discussion leaders,

and speakers to accomplish conference objectives.

C. The degree to which the application demonstrates that all key

personnel have education and expertise relative to the conference

objectives, are informed about the transmission of HIV, and understand

nationwide information and education efforts currently underway that

may affect, and be affected by, the proposed conference.

5. Budget Justification and Adequacy of Facilities: (not scored)

The proposed budget will be evaluated on the basis of its

reasonableness, concise and clear justification, consistency with the

intended use of cooperative agreement funds, and the extent to which

the applicant documents financial support from other sources.

Executive Order 12372 Review

This program is not subject to the Executive Order 12372 review.

Public Health System Reporting Requirements

This program is not subject to the Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

The Catalog of Federal Domestic Assistance number is 93.941.

Submission Requirements and Deadlines

A. Letter of Intent (LOI)

1. One original and two copies of the LOI must be postmarked by the

following deadline dates in order to be considered. (Facsimiles are not

acceptable.) An invitation to submit an application does not constitute

a commitment to fund.

2. Letter of Intent Due Dates: January 31, 1998.

B. Application

One original and two copies of the invited application must be

submitted on PHS Form 5161-1 (OMB Number 0937-0189) and must be

postmarked by the date specified in the acceptance letter in order to

be considered in the application cycles.

Applications may be accepted by CDC only after the LOI has been

reviewed by CDC and written invitation from CDC has been received by

prospective applicant. Availability of funds may limit the number of

Letters of Intent, regardless of merit, that receive an invitation to

submit an application.

C. Addresses for Submission of Letter of Intent and Invited

Applications

One original and two copies of the Letters of Intent and invited

application must be postmarked on or before the deadline date and

mailed to: Juanita Dangerfield, Grants Management Branch, Procurement

and Grants Office, Centers for Disease Control and Prevention (CDC),

255 East Paces Ferry Road, NE., Mailstop E-15, Atlanta, GA 30305.

D. Deadlines

Letters of Intent and Application shall be considered as meeting

the deadline if they are either:

1. Received on or before the deadline date, or

2. Postmarked on or before the deadline date and received in time

for submission to the independent review group. (Applicants must

request a legibly dated U.S. Postal Service postmark or obtain a

legibly dated receipt from a commercial carrier or the U.S. Postal

Service. Private metered postmarks will not be acceptable as proof of

timely mailing.)

E. Late Applications

Applications that do not meet the criteria in D.1. or D.2. above

are considered late applications and will be returned to the applicant

without review.

Other Requirements

Program Review Panel

Recipients must comply with the document entitled Content of

HIV/AIDS-Related Written Materials, Pictorials, Audiovisuals,

Questionnaires, Survey Instruments, and Educational Sessions in Centers

for Disease Control Assistance Programs (June 1992) (a copy is in the

application kit). To meet the requirements for a Program Review Panel,

recipients are encouraged to use an existing Program Review Panel such

as the one created by the State health department's HIV/AIDS prevention

program. If the recipient forms its own Program Review Panel, at least

one member must also be an employee (or a designated representative) of

an appropriate health or educational agency, consistent with the

Content Guidelines. The names of review panel members must be listed on

the Assurance of Compliance form (CDC Form 0.1113) which is also

included in the application kit.

Use of CDC Name

The conference organizer(s) may use CDC's name only in factual

publicity for the conference, and should understand that CDC

involvement in the conference does not necessarily indicate support for

the organizer's general policies, activities, or products.

Where To Obtain Additional Information

To receive additional written information, call (404) 332-4561. You

will be asked to leave your name, address, and phone number, and refer

to Announcement Number 802. You will receive a complete program

announcement, a list of the relevant ``Healthy People 2000'' HIV

objectives, and the addresses and phone numbers for CDC contact

personnel. CDC will not send application kits by facsimile or express

mail unless the cost for the latter is paid by the addressee.

This and other CDC announcements are also available through the CDC

homepage on the Internet. The address for the CDC homepage is http://

www.cdc.gov.

If you have questions after reviewing the contents of all the

documents, business management technical assistance may be obtained

from Ms. Juanita Dangerfield, Grants Management Specialist, Grants

Management Branch, Procurement and Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Mailstop

E-15, Room 300, Atlanta, GA 30305, telephone (404) 842-6577.

Programmatic technical assistance may

[[Page 66111]]

be obtained from Ms. Linda LaChanse, Program Analyst, Training and

Technical Support Systems Branch, Division of HIV/AIDS Prevention,

National Center for HIV/STD/TB Prevention, Centers for Disease Control

and Prevention (CDC), 1600 Clifton Road, NE., Mailstop E-40, Atlanta,

GA 30333, telephone (404) 639-0964.

Please refer to Announcement Number 802 when requesting

information, submitting your Letter of Intent and submitting the

invited application in response to the announcement.

Potential applicants may obtain a copy of Healthy People 2000 (Full

Report, Stock No. 017-001-00474-0) or Healthy People 2000 (Summary

Report, Stock No. 017-001-00473-1) through the Superintendent of

Documents, Government Printing Office, Washington, DC 20402-9325,

telephone (202) 512-1800. Single copies of CDC's Strategic Plan for

Preventing Human Immunodeficiency Virus (HIV) Infection (July 8, 1992)

can be obtained by calling the CDC National AIDS Clearinghouse at (800)

458-5231.

Dated: December 11, 1997.

Joseph R. Carter,

Acting Associate Director for Management and Operations, Centers for

Disease Control and Prevention (CDC).

[FR Doc. 97-32867 Filed 12-16-97; 8:45 am]

BILLING CODE 4163-18-P